text_1: Aspirin cuts heart attacks, not deaths or strokes
text_2: This story demonstrates a careful and contextual analysis of the evidence, making clear what the study did show and what it didn’t. The trials aren’t long enough to show downstream effects on mortality, which is, unfortunately, a problem with most primary prevention trials. The real question here (which is not answered but is discussed) is what is the balance of benefits and harms.